Nome do produto |
adriamicinal |
Sinônimos |
13-Diidrodoxorrubicina; 10-((3-Amino-2,3,6-trideoxi-alfa-L-lyxo-hexopiranosil)oxi)-8-(1,2-dihidroxietil)-7,8,9,10-tetraidro-6,8,11-triidroxi-1-metoxi-5,12-naftacenediona; 5,12-Naftacenediona, 10-((3-amino-2,3,6-trideoxi-alfa-L-lyxo-hexopiranosyl)oxy)-8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-; 3-(1,2-dihidroxietil)-3,5,12-triidroxi-10-metoxi-6,11-dioxo-1,2,3,4,6,11-hexahidrotetracen-1-ilo 3-amino-2,3,6-trideoxi-L-lyxo-hexopiranosídeo; Cloridrato de (1S,3S)-3-[(1S)-1,2-dihidroxietil]-3,5,12-triidroxi-10-metoxi-6,11-dioxo-1,2,3,4,6,11-hexahidrotetracen-1-ilo 3-amino-2,3,6-trideoxi-alfa-L-lyxo-hexopiranosídeo (1:1) |
Nome em inglês |
adriamycinol;13-Dihydrodoxorubicin; 10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-; 3-(1,2-dihydroxyethyl)-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-L-lyxo-hexopyranoside; (1S,3S)-3-[(1S)-1,2-dihydroxyethyl]-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride (1:1) |
Fórmula molecular |
C27H32ClNO11 |
Peso Molecular |
581.9961 |
InChI |
InChI=1/C27H31NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15-17,22,29-31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,16-,17-,22+,27-;/m0./s1 |
CAS Registry Number |
141434-67-5 |
Estrutura Molecular |
|
Ponto de ebulição |
828.7°C at 760 mmHg |
O ponto de inflamação |
455°C |
Pressão de vapor |
4.26E-29mmHg at 25°C |
Símbolos de perigo |
|
Códigos de risco |
|
Descrição da Segurança |
|
|